Viewing Study NCT05023551

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-11 @ 2:43 AM
Study NCT ID: NCT05023551
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-16
First Post: 2021-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
Sponsor: Sumitomo Pharma America, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High Grade Glioma View
None Glioblastoma Multiforme View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High grade glioma View
None Glioblastoma Multiforme (GMB) View
None Brain Tumor View
None Emopamil binding protein View
None 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase View